Company Overview

VIR BIOTECHNOLOGY, INC.

VIR
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
69M
2025 FY
Net Income
-438M
2025 FY
Shares Outstanding
139M
2025 FY
EPS
-3.16USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1706431
Exchange
Nasdaq
Location
US